Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9331074rdf:typepubmed:Citationlld:pubmed
pubmed-article:9331074lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9331074lifeskim:mentionsumls-concept:C0017638lld:lifeskim
pubmed-article:9331074lifeskim:mentionsumls-concept:C0242406lld:lifeskim
pubmed-article:9331074lifeskim:mentionsumls-concept:C0007585lld:lifeskim
pubmed-article:9331074lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:9331074lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:9331074lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:9331074lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:9331074lifeskim:mentionsumls-concept:C0681842lld:lifeskim
pubmed-article:9331074lifeskim:mentionsumls-concept:C0877853lld:lifeskim
pubmed-article:9331074lifeskim:mentionsumls-concept:C1550147lld:lifeskim
pubmed-article:9331074lifeskim:mentionsumls-concept:C2004457lld:lifeskim
pubmed-article:9331074pubmed:issue19lld:pubmed
pubmed-article:9331074pubmed:dateCreated1997-10-28lld:pubmed
pubmed-article:9331074pubmed:abstractTextBoth tumor metabolism and its response to cytotoxic drugs are intrinsic properties of tumor cells. It is therefore likely that there is a relationship between the two properties, however subtle and complex, wherein the metabolic characteristics of tumor cells can reflect the inherent response (resistance or sensitivity) of these cells to cytotoxic drugs. We used artificial neural network analysis to show that it is possible to distinguish, prior to treatment, between drug-resistant and drug-sensitive human glioma cell cultures from their metabolic profiles, as given by high-resolution proton nuclear magnetic resonance spectra of the cell extracts, and to predict their cellular response to the chemotherapeutic drug 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in vitro. The results suggest that neural network analysis of tumor nuclear magnetic resonance spectra has potential as a prognostic tool for determining treatment of gliomas, ultimately noninvasively, and may be used to provide information about the metabolic pathways involved in drug response that may be helpful in developing novel treatments for these tumors.lld:pubmed
pubmed-article:9331074pubmed:languageenglld:pubmed
pubmed-article:9331074pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9331074pubmed:citationSubsetIMlld:pubmed
pubmed-article:9331074pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9331074pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9331074pubmed:statusMEDLINElld:pubmed
pubmed-article:9331074pubmed:monthOctlld:pubmed
pubmed-article:9331074pubmed:issn0008-5472lld:pubmed
pubmed-article:9331074pubmed:authorpubmed-author:BranstonN MNMlld:pubmed
pubmed-article:9331074pubmed:authorpubmed-author:ThomasD GDGlld:pubmed
pubmed-article:9331074pubmed:authorpubmed-author:WilliamsS RSRlld:pubmed
pubmed-article:9331074pubmed:authorpubmed-author:DarlingJ LJLlld:pubmed
pubmed-article:9331074pubmed:authorpubmed-author:AshmoreS MSMlld:pubmed
pubmed-article:9331074pubmed:authorpubmed-author:El-DeredyWWlld:pubmed
pubmed-article:9331074pubmed:issnTypePrintlld:pubmed
pubmed-article:9331074pubmed:day1lld:pubmed
pubmed-article:9331074pubmed:volume57lld:pubmed
pubmed-article:9331074pubmed:ownerNLMlld:pubmed
pubmed-article:9331074pubmed:authorsCompleteYlld:pubmed
pubmed-article:9331074pubmed:pagination4196-9lld:pubmed
pubmed-article:9331074pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9331074pubmed:meshHeadingpubmed-meshheading:9331074-...lld:pubmed
pubmed-article:9331074pubmed:meshHeadingpubmed-meshheading:9331074-...lld:pubmed
pubmed-article:9331074pubmed:meshHeadingpubmed-meshheading:9331074-...lld:pubmed
pubmed-article:9331074pubmed:meshHeadingpubmed-meshheading:9331074-...lld:pubmed
pubmed-article:9331074pubmed:meshHeadingpubmed-meshheading:9331074-...lld:pubmed
pubmed-article:9331074pubmed:meshHeadingpubmed-meshheading:9331074-...lld:pubmed
pubmed-article:9331074pubmed:meshHeadingpubmed-meshheading:9331074-...lld:pubmed
pubmed-article:9331074pubmed:meshHeadingpubmed-meshheading:9331074-...lld:pubmed
pubmed-article:9331074pubmed:meshHeadingpubmed-meshheading:9331074-...lld:pubmed
pubmed-article:9331074pubmed:meshHeadingpubmed-meshheading:9331074-...lld:pubmed
pubmed-article:9331074pubmed:meshHeadingpubmed-meshheading:9331074-...lld:pubmed
pubmed-article:9331074pubmed:year1997lld:pubmed
pubmed-article:9331074pubmed:articleTitlePretreatment prediction of the chemotherapeutic response of human glioma cell cultures using nuclear magnetic resonance spectroscopy and artificial neural networks.lld:pubmed
pubmed-article:9331074pubmed:affiliationDepartment of Neurological Surgery, Institute of Neurology, London, United Kingdom. W.ElDeredy@ion.ucl.ac.uklld:pubmed
pubmed-article:9331074pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9331074pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9331074lld:pubmed